News Daily News New Biomarker on the Block, FGF-23, May Aid in Secondary-Event Prediction Following ACS Yael L. Maxwell April 18, 2018
News Daily News Another Observational Study Supports Role for Genotype-Guided Antiplatelet Choices Post-PCI Yael L. Maxwell April 04, 2018
News Conference News ACC 2018 Perioperative Beta-blockade for Noncardiac Surgery Increases Death, Stroke at 1 Year Yael L. Maxwell March 15, 2018
News Conference News ACC 2018 Gout Drug Febuxostat Linked to More CV Deaths Without Uptick in CV Events: CARES Trial Caitlin E. Cox March 14, 2018
News Conference News ACC 2018 Canakinumab Falls Short of Halting Progression to Diabetes in Patients at Risk: CANTOS Michael O'Riordan March 12, 2018
News Conference News ACC 2018 SECURE-PCI Comes Up Short for Statin Preloading in ACS Patients Michael O'Riordan March 11, 2018
News Conference News ACC 2018 ODYSSEY Delivers a Win for Alirocumab in ACS, With a Signal of Survival Benefit Michael O'Riordan March 10, 2018
News Daily News One in Five CABG Patients Develop New-Onset Atrial Fibrillation: EXCEL Michael O'Riordan February 12, 2018
News Conference News ISC 2018 COMPASS Analysis Explores Impact of Low-Dose Rivaroxaban Plus Aspirin on Stroke Todd Neale January 25, 2018
News Daily News Heart Failure Risk Following 'Silent' MI Warrants Scrutiny: ARIC Analysis Caitlin E. Cox January 08, 2018
News Daily News NOACs May Carry Lower Risk of Intraocular Hemorrhage Than Warfarin L.A. McKeown January 02, 2018
News Conference News AHA 2017 Two FOURIER Subgroup Analyses Show Added Benefit of Evolocumab in Those With PAD, Prior MI Yael L. Maxwell November 13, 2017
News Daily News Preventing Dementia May Be Another Reason to Take Oral Anticoagulants for A-fib Todd Neale October 25, 2017
News Daily News DOACs Not Associated With Major Bleeding, Mortality: Observational Analysis Michael O'Riordan October 19, 2017
News Daily News ‘J-Curve’ in Hypertension May Be Explained by Differences in Patient Characteristics Todd Neale September 26, 2017
News Daily News Quitting Chronic, Low-Dose Aspirin May Boost Risk of Cardiovascular Events Todd Neale September 25, 2017
News Daily News Study Questions Incremental Benefit of Beta-Blockers After Acute MI Michael O'Riordan September 21, 2017
News Industry News New FOURIER Analysis Shows Repatha® (Evolocumab) Reduces Cardiovascular Events In Patients With Diabetes September 15, 2017
News Features COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict Todd Neale September 15, 2017